Atlas Trials

Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.

Clinical trial NCT03088670 · COMPLETED

Trial details

NCT number
NCT03088670
Sponsor
SatRx LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2013-04-23
Primary completion
2014-03-30
Enrollment
299

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.